Tianeptine, initially developed as the mood-boosting drug in the 1980s, has generated considerable debate globally . Unlike most antidepressants which act by increasing serotonin levels, tianeptine suggests to improve mood reuptake and affects glutamate , leading distinct outcomes . Its availability through unregulated channels , often bypassing pr